A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

April 4, 2023

Study Completion Date

April 4, 2023

Conditions
Hemophilia A
Trial Locations (13)

119049

Morozovskaya Children's City Clinical Hospital of the Department of Healthcare of the city of Moscow, Moscow

191186

City Polyclinic No. 37, Saint Petersburg

344015

Regional Children's Clinical Hospital, Rostov-on-Don

360032

"State Budgetary Institution of Healthcare Republican children's clinical hospital of the Ministry of Health of the Kabardino-Balkar Republic", Nal'chik

394024

Voronezh Regional Children's Clinical Hospital No. 1, Voronezh

400138

Volgograd Regional Clinical Oncological Dispensary, Volgograd

420034

City Children's Hospital No. 1, Kazan'

454087

Chelyabinsk Regional Children's Clinical Hospital, Chelyabinsk

620149

"State Autonomous Healthcare Institution of the Sverdlovsk Region Regional Children's Clinical Hospital", Yekaterinburg

630087

State Novosibirsk Regional Clinical Hospital, Novosibirsk

660074

Krasnoyarsk Regional Clinical Center for Maternal and Child Health, Krasnoyarsk

680003

Children's Regional Clinical Hospital, Khabarovsk

690002

Regional Children's Clinical Hospital No. 1, Vladivostok

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY